@article{Saini_Gupta_Arora_Virmani_2018, title={To study the association of high sensitivity C-reactive protein with metabolic syndrome}, volume={6}, url={https://www.msjonline.org/index.php/ijrms/article/view/4306}, DOI={10.18203/2320-6012.ijrms20180300}, abstractNote={<p class="abstract"><strong>Background:</strong> Metabolic Syndrome is a constellation of dyslipidemia (elevated triglycerides, low high-density lipoproteins (HDL)), elevation of arterial blood pressure (BP), dysregulated glucose homeostasis, and increased abdominal obesity.</p><p class="abstract"><strong>Methods:</strong> We studied the association of high sensitivity C-reactive protein with metabolic syndrome by case-control method in our tertiary care hospital in West U.P.</p><p class="abstract"><strong>Results:</strong> The mean age of cases and controls was 52.6 ± 7.7 and 51.4±7.0 years, respectively. There were 25 (50%) male and 25 (50%) female in case groups, and 27 (54%) males and 23 (46%) females in control group. Our analysis revelaed that there was a significant association between hs-CRP and the central obesity when compared in case-control group (3.57 vs 0.96 mg/L) (p value <0.001). There was no significant association between hs-CRP and high triglycerides, hypertension, diabetes, and reduced high density lipoprotein cholesterol.</p><p class="abstract"><strong>Conclusions:</strong> Raised hsCRP level can be considered as a surrogate marker of chronic inflammation in patients with metabolic syndrome.</p>}, number={2}, journal={International Journal of Research in Medical Sciences}, author={Saini, Vinod and Gupta, Abhishek and Arora, Mayank and Virmani, S. K.}, year={2018}, month={Jan.}, pages={572–576} }